Clinical features of abnormal α-fetoprotein in 15 patients with chronic viral hepatitis B after treatment with antiviral drugs

doi:10.4254/wjh.v17.i1.100392

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (131)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-5)

Sum=123

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=2

Jan 27, 2025 (publication date) through Jan 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Jan 27, 2025; 17(1): 100392
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.100392

Table 4 Changes in -fetoprotein before and after hormone therapy

Parameters	Pre-hormone therapy	1 months after hormone therapy	2-3 months after hormone therapy	*Z/t*	P value
AFP (μg/L)	32.96 (12.49-114.36)	15.38 (11.21-41.71)	5.2 (3.94, 9.44)¹	3.18	0.001

¹Using single-factor repeated measures one-way analysis of variance, the difference in alpha fetoprotein index between 2 and 3 months after hormone therapy and before treatment was significant.

AFP: Alpha fetoprotein.

Citation: Jiang ML, Xu F, Li JL, Luo JY, Hu JL, Zeng XQ. Clinical features of abnormal α-fetoprotein in 15 patients with chronic viral hepatitis B after treatment with antiviral drugs. World J Hepatol 2025; 17(1): 100392
URL: https://www.wjgnet.com/1948-5182/full/v17/i1/100392.htm
DOI: https://dx.doi.org/10.4254/wjh.v17.i1.100392